It belongs to a new group of medications called triple-agonist metabolic drugs because it activates three hormone receptors that help control appetite and metabolism
The agents comprehensive benefits render it an instrumental option for individuals aiming to achieve both significant weight reduction and heightened cardio protection
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication
Loss of Angiotensin-Converting Enzyme-2 Exacerbates Diabetic Cardiovascular Complications and Leads to Systolic and Vascular Dysfunction: A Critical Role of the Angiotensin II/AT1 Receptor Axis
Avoid fried foods, heavy cream sauces, fatty cuts of meat, full-fat dairy, and greasy fast food
GLP-1 is also an incretin hormone, enhancing insulin and suppressing glucagon secretion in the pancreas, thus lowering blood glucose